Detalhe da pesquisa
1.
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
Blood Adv
; 6(8): 2520-2534, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35244681
2.
Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.
J Clin Oncol
; 37(26): 2349-2359, 2019 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31356143